Results 11 to 20 of about 8,834,434 (252)
Harm Reduction Journal, 2020 Background Due to the high prevalence of mental disorders among people with opioid use disorder, the objective of this study was to determine the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention ...
Kristen A. Morin +6 more
doaj +1 more source
BMC Psychiatry, 2022 Background The last decade has shown a remarkable increase in the rates of illicit opioid use in Canada and internationally, which is associated with large increases in opioid related morbidity and mortality.
Joseph Sadek, Joseph Saunders
doaj +1 more source
PLoS ONE, 2020 ObjectiveThe objective of this study was to evaluate the relationship between concurrent physician-based mental health services, all-cause mortality, and acute health service use for individuals enrolled in Opioid Agonist Treatment in Ontario, Canada ...
Kristen A Morin +6 more
doaj +1 more source
A social ecological model (SEM) to exploring barriers of and facilitators to the implementation of Opioid Agonist Treatment (OAT) programmes in prisons [PDF]
, 2021 First paragraph: Opioid agonist treatment (OAT), an evidence-based treatment for opioid dependence, has been associated with reductions in illicit drug use, injecting drug use, the sharing of injecting equipment and an increase in adherence to ...
Komalasari, Rita +5 more
core +1 more source
, 2023 Comparison of Opioid Agonist Treatment related characteristics between non-injecting and injecting drug users.
Saroj Prasad Ojha (8975855) +4 more
core +1 more source
Journal of Sleep Sciences, 2022 Substance use disorder is a critical social and health problem placing a tremendous burden on the country's health care system. Harm reductionpolicy focusing on using opioid agonist make up the majority of the maintenance treatment options.
Lahya Afshari Saleh +3 more
doaj +1 more source
Access to Opioid Agonist Treatment during COVID-19 Project
, 2022 Data for methadone clinics, travel times, and census data used in "Access to Opioid Agonist Treatment during COVID-19 Public Transport Disruptions"
Higgins, Chrisopher D. +3 more
core +1 more source
Substance Abuse Treatment, Prevention, and Policy, 2019 Objective The objective was to characterize the relationship between geography, concurrent psychiatric services, all-cause mortality, and acute health care use for individuals enrolled in Opioid Agonist Treatment, in Ontario, Canada. Methods We conducted
Kristen A. Morin +7 more
doaj +1 more source
Measuring opioid agonist treatment stigma and its effects: An exploration of pharmacist attitudes and consumer treatment outcomes [Poster Presentation] [PDF]
, 2023 Background: Opioid agonist treatment consumers can experience stigma when collecting and consuming their medications at community pharmacies. We sought to evaluate if pharmacist attitudes and behaviours towards opioid agonist treatment customers ...
Caruana, Theresa ; https://orcid.org/
core +1 more source
Scientific Reports, 2023 Opioid addiction and the opioid overdose epidemic are becoming more serious, and the development of therapeutic agents is essential for the pharmacological treatment of substance use disorders.
Soichiro Ide +4 more
doaj +1 more source